PineEnemy - Exploring the NEmatode-MYcobiota interactions in Pine Wilt Disease
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Jornadas MED
Abstract
Pine wilt disease (PWD) is one of the most important threats to conifer forests in Europe [1] and worldwide [2], causing severe economic and environmental damages. This complex disease results from the interaction between three biological elements: the pathogenic agent Bursaphelenchus xylophilus, also known as pinewood nematode (PWN); the insect-vector (cerambycid beetles of the genus Monochamus) [3], and the host tree, mostly from Pinus spp. [4]. In 1999, B. xylophilus was firstly identified in maritime pines (Pinus pinaster) in Portugal and in Europe [1, 5]. Despite a nationwide monitoring system, enforcement of strict phytosanitary measures and constraints implemented after PWN detection, this devastating problem has spread quickly in Portuguese mainland, Madeira Island [5] and Northern Spain [6].
As a migratory endoparasite, once inside susceptible tree, PWN has the ability to feed on the living parenchyma of the epithelial cells in the resin canals, causing a reduction in water flux and ultimately cessation of resin flow. In the later stages of the disease, PWN assumes a mycetophagous phase. The development of the PWN population appears to be strongly associated with fungi that colonize the declining trees [3]. Fungi harboured in weakened pines are seen as essential for the ongoing development and completion of the PWN life-cycle, affecting not only PWN reproduction [8] but also the number of individuals carried by the insect-vector [9-10].
Through a spatio-temporal analysis, PineEnemy will focus on the characterization of the structure and dynamics of the nematode-fungi interactions through culturable and non-culturable approaches with special emphasis in metagenomics analysis. Our aim is to understand if PWN-associated mycobiota plays a key-role in the development of PWD, in interaction with PWN and insect-vector, and into which extend can be targeted to disrupt the disease cycle.